Dr. Jon Christopher Stringer, MD

Dr. Stringer practices at Crouse Hospital in Syracuse, New York, part of Crouse Health.

Dr. Stringer's NPI, 1306827142, was assigned on November 9, 2005. Dr. Stringer holds New York license 141135.

Dr. Stringer's primary practice is Crouse Hospital, at 736 Irving Avenue, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 470-7449.

Dr. Stringer's primary practice is Crouse Hospital in Syracuse, New York, part of Crouse Health. Dr. Stringer is also affiliated with Upstate University Hospital. Dmand AI also links Dr. Stringer to 2 more hospitals, 2 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stringer practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Stringer's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Stringer is licensed in New York.

CMS data shows 1,152 Medicare services from Dr. Stringer across 22 procedure codes in 2024, for 111 Medicare patients. Medicare paid $69,632 for them.

CMS counts 111 Medicare patients who saw Dr. Stringer in 2024. The largest group is 85 and over, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stringer's median patient age at 71, with 44% women.

In 2024, Dr. Stringer wrote 4,539 Medicare Part D claims for 183 patients. 84% of them were for generic drugs. CMS names the drug for 3,857 of them, across 106 drugs with 11 or more claims each, at $541,230 in total drug cost. In 2023, CMS named 3,765 claims across 106 drugs.

Dr. Stringer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of removal of skin lesions by Dr. Stringer, more than 68% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Stringer to 3 clinical trials. Conditions studied include Headache, Migraine Disorders and Diabetes Mellitus, Type 2. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Stringer that name 3 trials.

CMS Open Payments shows 338 general payments to Dr. Stringer from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Janssen Research & Development, LLC paid the most, $2,099. It also lists 8 research payments totaling $36,112 from 2016 to 2023, naming 3 clinical trials.